Marie‐Noëlle Lavaut

Medicine · Health Sciences

20h-index2.6kcitations51works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(15), Cancer Cells and Metastasis(12), Cancer, Hypoxia, and Metabolism(8), Cancer Research and Treatments(8), Cell Adhesion Molecules Research(6)

Publications51 total

Supplementary data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S2 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S2 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S5 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S1 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S1 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S5 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S4 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S3 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S4 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Supplementary data from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
Figure S3 from LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
2023Open Access
LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker
Cancer Research·2017· 104 citedOpen Access
Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
Nature Communications·2017· 392 citedOpen Access
Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness
Journal of Clinical Investigation·2016· 206 citedOpen Access
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
Proceedings of the National Academy of Sciences·2015· 450 citedOpen Access
Metabolic rewiring of PDAC: When collagen feeds tumour cells.
Pancreatology·2014
Prognostic factors of response to adjuvant chemotherapy after curative resection for pancreatic ductal adenocarcinoma: Prognostic impact of CDA, predictive value of DPD for 5FU efficiency, and hENT1 for gemcitabine.
Journal of Clinical Oncology·2014· 1 cited
page 1 of 3Next →

Frequent Co-authors

Claude Allasia(23), Stéphane Garcia(22), Colette Charpin(22), Juan Iovanna(21), Richard Tomasini(20), Sophie Vasseur(20), Véronique Secq(20), Fabienne Guillaumond(19), Sophie Lac(18), Mehdi Ouaïssi(17), Julie Roques(17), Jérémy Nigri(17), Julie Leca(17), Pascal Bonnier(17), Christian Bressy(15), Daniel Pietrasz(15), Samuel Granjeaud(15), Jean‐Baptiste Bachet(15), Thi-Thien Bui(14), L Andrac(14)